Autolus Therapeutics AUTL 深 沪
已收盘 11-13 16:00:00 美东时间
1.17
-0.020
-1.68%
华盛通- 最 高1.2399
- 今 开1.20
- 成交量 179.56万股
- 最 低 1.16
- 昨 收 1.19
- 总市值 31.16万
- 52周最高 2.58
- 市盈率 静 --
- 换手率 0.67%
- 52周最低 1.12
- 委 比 -46.66%
- 总股本 0.00亿
- 历史最高 53.24
- 量 比 0.46
- 振 幅 6.71%
- 历史最低 1.105
- 每 手 1
- 风险率 0.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Autolus Therapeutics Plc收跌1.68%，成交额211.5万美元
11月14日，Autolus Therapeutics Plc（AUTL）收跌1.68%，报1.17美元，成交额211.5万美元，市值3.11亿美元。 行情数据...
11-14 07:23
Autolus Therapeutics Q3 2026 Earnings Call Transcript
Autolus Therapeutics (NASDAQ:AUTL) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benz...
11-10 22:28
Autolus Therapeutics Plc收涨1.59%，成交额154.25万美元
11月7日，Autolus Therapeutics Plc（AUTL）收涨1.59%，报1.28美元，成交额154.25万美元，市值3.41亿美元。 行情数据...
11-07 07:16
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026
Autolus Therapeutics announced the online publication of three abstracts for the upcoming ASH Annual Meeting. The first abstract highlights sustained measurable residual disease (MRD) responses and recovery from cytopenias in adult relapsed/refractory B-ALL patients treated with obe-cel. The second abstract demonstrates concordance between ddPCR and qPCR assays for monitoring obe-cel levels, supporting the use of qPCR in clinical practice. The th...
11-04 14:15
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Autolus Therapeutics plc announced that its Compensation Committee granted stock option awards and restricted stock units (RSUs) totaling 75,400 American Depositary Shares and 129,310 RSUs to 15 employees under the 2025 Inducement Plan. The awards, granted on October 21, 2026, have an exercise price of $1.66 per share, vesting over four years. The stock options have a ten-year term, with 25% vesting after one year and the remainder in monthly ins...
11-03 21:45
美股大行评级 | 潜在涨幅2250.23%！艾伯维获大摩等多家大行上调目标价，最高340美元
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从50美元升至51美元；HC Wainwright & Co.：上调伊诺维奥制药评级至"买入"，目标价5美元
11-03 18:20
Autolus Therapeutics Plc收跌3.8%，成交额254.66万美元
10月31日，Autolus Therapeutics Plc（AUTL）收跌3.8%，报1.52美元，成交额254.66万美元，市值4.05亿美元。 行情数据...
10-31 06:13
Autolus Therapeutics to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026
Autolus Therapeutics plc will release its third quarter 2026 financial results and operational highlights before U.S. markets open on November 10, 2026. Management will host a conference call and webcast at 8:30am EST / 1:30pm GMT. Participants must pre-register via the provided link to access the call. A live audio webcast and replay will be available on the company's website. Autolus is a commercial-stage biopharmaceutical company developing ne...
10-26 20:15
Autolus Therapeutics Plc收跌2.53%，成交额234.17万美元
10月24日，Autolus Therapeutics Plc（AUTL）收跌2.53%，报1.54美元，成交额234.17万美元，市值4.1亿美元。 行情数据...
10-24 06:16
Autolus Therapeutics Plc收跌6.98%，成交额383.49万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:15
